As of 2025-09-18, the Relative Valuation of Viracta Therapeutics Inc (VIRX) is (116.36) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.08 USD, the upside of Viracta Therapeutics Inc based on Relative Valuation is -149669.1%.
The range of the Relative Valuation is (120.03) - (116.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.9x - 13.9x | 13.9x |
| Forward P/E multiples | 12.6x - 13.5x | 13.0x |
| Fair Price | (120.03) - (116.58) | (116.36) |
| Upside | -154386.5% - -149946.6% | -149669.1% |
| Date | P/E |
| 2025-07-16 | -0.00 |
| 2025-07-15 | -0.00 |
| 2025-07-14 | -0.00 |
| 2025-07-11 | -0.00 |
| 2025-07-10 | -0.00 |
| 2025-07-09 | -0.00 |
| 2025-07-08 | -0.00 |
| 2025-07-07 | -0.00 |
| 2025-07-03 | -0.00 |
| 2025-07-02 | -0.00 |
| 2025-07-01 | -0.00 |
| 2025-06-30 | -0.00 |
| 2025-06-27 | -0.00 |
| 2025-06-26 | -0.00 |
| 2025-06-25 | -0.00 |
| 2025-06-24 | -0.00 |
| 2025-06-23 | -0.00 |
| 2025-06-20 | -0.00 |
| 2025-06-18 | -0.00 |
| 2025-06-17 | -0.00 |
| 2025-06-16 | -0.00 |